Search - tctmd.com

Displaying 1 - 20 of 166

Sort: Relevancy | Date

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

Presentation TCT 2019

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

Presenter: Suzanne Baron

September 29, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

LVOTO Solution III: Batman

Presenter: Tarek Helmy, MD

September 28, 2019

Presentation TCT 2019

LVOTO Solution II: LAMPOON

Presenter: James McCabe

September 28, 2019

Presentation TCT 2019

LVOTO Solution I: Alcohol Septal Ablation

Presenter: Dee Dee Wang

September 28, 2019

Presentation TCT 2019

Essentials of LVOTO Screening (And Device Specificity)

Presenter: Omar Khalique

September 28, 2019

Presentation TCT 2019

Valve-in-Ring (Mitral): Acute and Long-Term Outcomes

Presenter: Sung-Han Yoon

September 28, 2019

Presentation TCT 2019

Valve-in-Valve (Mitral): Acute and Long-Term Outcomes

Presenter: Mayra Guerrero

September 28, 2019

Presentation TCT 2019

Valve-in-MAC (Mitral): Acute and Long-Term Outcomes

Presenter: Vinayak Bapat

September 28, 2019

Presentation TCT 2019

Transseptal VII: AltaValve — Device Description, Results, and Ongoing Studies

Presenter: Philippe Genereux

September 28, 2019

Presentation TCT 2019

PARTNER 2 Trial and Registry: Impact of Left And Right Ventricular Longitudinal Systolic Strain Following Transcatheter and Surgical Aortic Valve Replacement

Presenter: Philippe Pibarot

September 28, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Presentation TCT 2019

Transseptal VI: Cardiovalve — Device Description, Results, and Ongoing Studies

Presenter: Francesco Maisano

September 28, 2019

Presentation TCT 2019

Transseptal V: M3 — Device Description, Results, and Ongoing Studies

Presenter: John Webb

September 28, 2019

Presentation TCT 2019

Transseptal IV: EVOQUE — Device Description, Results, and Ongoing Studies

Presenter: Howard Herrmann

September 28, 2019

Advertisement

Predicting Final Valve Position After TAVR: Different Devices, Different Success

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

LVOTO Solution III: Batman

LVOTO Solution II: LAMPOON

LVOTO Solution I: Alcohol Septal Ablation

Essentials of LVOTO Screening (And Device Specificity)

Valve-in-Ring (Mitral): Acute and Long-Term Outcomes

Valve-in-Valve (Mitral): Acute and Long-Term Outcomes

Valve-in-MAC (Mitral): Acute and Long-Term Outcomes

Transseptal VII: AltaValve — Device Description, Results, and Ongoing Studies

PARTNER 2 Trial and Registry: Impact of Left And Right Ventricular Longitudinal Systolic Strain Following Transcatheter and Surgical Aortic Valve Replacement

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Transseptal VI: Cardiovalve — Device Description, Results, and Ongoing Studies

Transseptal V: M3 — Device Description, Results, and Ongoing Studies

Transseptal IV: EVOQUE — Device Description, Results, and Ongoing Studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content